Docetaxel and Cisplatin Chemotherapy With or Without High Dose Proton Pump Inhibitor in Metastatic Breast Cancer
Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
The objectives of this study are to evaluate the efficacy and tolerability of high dose
proton pump inhibitor combined with chemotherapy in metastatic breast cancer.